Mode
Text Size
Log in / Sign up
N/A N=51 Randomized

The Role of a Semi-Quantitative Urine Pregnancy Test and Pregnancy Questionnaire After Uterine Evacuation for Undesired Pregnancy of Uncertain Location

Follow-up After Uterine Evacuation

Enrolled (actual)
51
Serious AEs
0.0%
Results posted
Jul 2014
Primary outcome: Primary: Number of Women in Each Group Who Require a Return Visit to the Clinic for a Serum hCG Measurement, Ultrasound or Clinical Examination at One Week to Confirm Complete Evacuation — 3; 17 participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
dBest semi-quantitative urine pregnancy test (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
Planned Parenthood League of Massachusetts
Primary completion
Mar 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Women in Each Group Who Require a Return Visit to the Clinic for a Serum hCG Measurement, Ultrasound or Clinical Examination at One Week to Confirm Complete Evacuation
3; 17
SECONDARY
Patient Compliance With Each Follow-up Method
24; 12
SECONDARY
Patient Satisfaction With Each Follow-up Method
22; 6

Summary

The primary aim of this study is to determine if a self-administered semi-quantitative urine pregnancy test and telephone pregnancy symptom questionnaire can reduce the percentage of women with a complete uterine evacuation who require a clinic or lab visit to confirm completion. The investigators hypothesize that women with complete uterine evacuation will be less likely to require a follow-up clinic or lab visit by using a standardized pregnancy questionnaire and home SQ-UPT, than by using serum hCG as the objective measure of completion.

Eligibility Criteria

Inclusion Criteria

  • Women aged 18 years or older with an undesired pregnancy < 6 weeks gestation
  • Women with a positive urine pregnancy test
  • Proficiency in English
  • Working phone and subject willing to be contacted by phone.
  • Agreeing to surveys regarding demographics, follow-up preferences, and satisfaction with assigned follow-up method

Exclusion Criteria

  • Women with presence of a yolk sac or crown rump length visualized on ultrasound
  • Women with a gestational sac greater than 13mm [11]
  • High Suspicion for ectopic pregnancy

o Sign: Concerning adnexal mass seen on ultrasound in conjunction with pelvic pain and/or vaginal spotting

  • Hemodynamic instability

o Signs: heavy vaginal bleeding, hypotension, tachycardia

  • Pelvic Infection

o Signs: pain or fever

  • Medical conditions that contraindicate uterine evacuation according to PPLM clinic policy

o These include but are not limited to: a bleeding disorder or anticoagulation, significant cardiac disease, renal or liver failure, IUD in situ that cannot be removed

  • Unwilling or unable to comply with study follow-up procedures
  • Being in a situation where receiving phone calls or additional contact with research staff may endanger the privacy or safety of the subject (e.g. situations of domestic violence or abuse)
  • Inability to give informed consent
  • Previous participation in this study
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01596972). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search